BOUCHERVILLE, QC, April 15, 2026 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced today it will participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference for the third consecutive year. Mr. Roberge, President and CEO, will make a presentation on April 21 at 16:00 EST, and will be available for one-on-one meetings throughout the conference.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
LSL PHARMA GROUP INC. ANNOUNCES ITS PARTICIPATION IN THE "2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE"
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
